GlassScriptPhysician profile
Steven Krumholz
NPI 1043342199
$806.44
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.30 · 2021: $170 · 2022: $148 · 2023: $394 · 2024: $46.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.92 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $319.98 | 2022-2023 | Stelara, Simponi, Simponi Aria |
| Takeda Pharmaceuticals U.S.A., INC. | $144.55 | 2021-2024 | Entyvio |
| Pentax of America, INC. | $66.26 | 2020-2023 | Inspira |
| Abbvie INC. | $61.40 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $46.60 | 2021-2023 | Dificid |
| Redhill Biopharma INC. | $44.53 | 2022 | |
| Ferring Pharmaceuticals INC. | $34.38 | 2023 | Rebyota |
| Intercept Pharmaceuticals, INC. | $33.63 | 2022 | |
| Fisher & Paykel Healthcare INC | $20.32 | 2023 | Fisher & Paykel Healthcare |
| Gilead Sciences, INC. | $18.39 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.40 | 2024 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Krumholz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.